Literature DB >> 12271416

Dissociation of glucose tracer uptake and glucose transporter distribution in the regionally ischaemic isolated rat heart: application of a new autoradiographic technique.

Richard Southworth1, Jason L J Dearling, Rodolfo A Medina, Aiden A Flynn, R Barbara Pedley, Pamela B Garlick.   

Abstract

Fluorine-18 fluoro-2-deoxyglucose ((18)FDG) and carbon-14 2-deoxyglucose ((14)C-2-DG) are both widely used tracers of myocardial glucose uptake and phosphorylation. We have recently shown, using positron emission tomography (PET) and nuclear magnetic resonance, that ischaemia-reperfusion (I-R) causes differential changes in their uptake. We describe here the novel application of an autoradiographic technique allowing the investigation of this phenomenon at high resolution, using tracer concentrations of both analogues in the dual-perfused isolated rat heart. We also investigate the importance of glucose transporter (GLUT 1 and GLUT 4) distribution in governing the observed phosphorylated analogue accumulation. Hearts ( n=5) were perfused with Krebs buffer for 40 min, made regionally zero-flow ischaemic for 40 min and reperfused for 60 min with Krebs containing tracer (18)FDG (200 MBq) and tracer (14)C-2-DG (0.37 MBq). Hearts were then frozen and five sections (10 micro m) were cut per heart, fixed and exposed on phosphor storage plates for 18 h (for (18)FDG) and then for a further 9 days (for (14)C-2-DG). Quantitative digital images of tracer accumulation were obtained using a phosphor plate reader. The protocol was repeated in a second group of hearts and GLUT 1 and GLUT 4 distribution analysed. Post-ischaemic accumulation of (18)FDG-6-P was inhibited by 38.2%+/-1.7% and (14)C-DG-6-P by 19.0%+/-2.2%, compared with control ( P<0.05). After placing seven "lines of interrogation" across each heart section and analysing the phosphorylated tracer accumulation along them, a transmural gradient of both tracers was observed; this was highest at the endocardium and lowest at the epicardium. GLUT 4 translocated to the sarcolemma in the ischaemic/reperfused region (from 24%+/-3% to 59%+/-5%), while there was no cellular redistribution of GLUT 1. We conclude that since decreased phosphorylated tracer accumulation occurs after ischaemia-reperfusion, despite greater externalisation of GLUT 4, hexokinase or the affinities of the GLUT transporters are changed under these conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12271416     DOI: 10.1007/s00259-002-0922-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  6 in total

1.  Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.

Authors:  Koichi Morita; Chietsugu Katoh; Keiichiro Yoshinaga; Kazuyuki Noriyasu; Megumi Mabuchi; Takahiro Tsukamoto; Hiroyuki Kageyama; Tohru Shiga; Yuji Kuge; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-18       Impact factor: 9.236

Review 2.  PET imaging of cardiac hypoxia: opportunities and challenges.

Authors:  M G Handley; R A Medina; E Nagel; P J Blower; R Southworth
Journal:  J Mol Cell Cardiol       Date:  2011-07-14       Impact factor: 5.000

Review 3.  Hexokinase-mitochondrial interaction in cardiac tissue: implications for cardiac glucose uptake, the 18FDG lumped constant and cardiac protection.

Authors:  Richard Southworth
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

4.  Myocardial perfusion PET: a split function?

Authors:  Riemer H J A Slart
Journal:  J Nucl Cardiol       Date:  2011-08       Impact factor: 5.952

5.  Modeling non-linear kinetics of hyperpolarized [1-(13)C] pyruvate in the crystalloid-perfused rat heart.

Authors:  E Mariotti; M R Orton; O Eerbeek; J F Ashruf; C J Zuurbier; R Southworth; T R Eykyn
Journal:  NMR Biomed       Date:  2016-01-18       Impact factor: 4.044

6.  Assessing radiotracer kinetics in the Langendorff perfused heart.

Authors:  Erika Mariotti; Mattia Veronese; Joel T Dunn; Rodolfo A Medina; Philip J Blower; Richard Southworth; Thomas R Eykyn
Journal:  EJNMMI Res       Date:  2013-11-14       Impact factor: 3.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.